References
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- EttingerDSWoodDEAisnerDLNon-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyJ Natl Compr Canc Netw201715450453528404761
- DermanBAMilehamKFBonomiPDBatusMFidlerMJTreatment of advanced squamous cell carcinoma of the lung: a reviewTransl Lung Cancer Res20154552453226629421
- MolinaJRYangPCassiviSDSchildSEAdjeiAANon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipMayo Clin Proc200883558459418452692
- AlbergAJBrockMVSametJMEpidemiology of lung cancer: looking to the futureJ Clin Oncol200523143175318515886304
- ChenZFillmoreCMHammermanPSKimCFWongKKNon-small-cell lung cancers: a heterogeneous set of diseasesNat Rev Cancer201414853554625056707
- TanW-LJainATakanoANovel therapeutic targets on the horizon for lung cancerLancet Oncol2016178e347e36227511159
- ScottAMWolchokJDOldLJAntibody therapy of cancerNat Rev Cancer201212427828722437872
- GandaraDRHammermanPSSosMLLaraPNJrHirschFRSquamous cell lung cancer: from tumor genomics to cancer therapeuticsClin Cancer Res201521102236224325979930
- FujitaNTakagiSThe impact of Aggrus/podoplanin on platelet aggregation and tumour metastasisJ Biochem2012152540741322992842
- Martin-VillarEMegiasDCastelSYurritaMMVilaroSQuintanillaMPodoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transitionJ Cell Sci2006119Pt 214541455317046996
- WickiAChristoforiGThe potential role of podoplanin in tumour invasionBr J Cancer20079611517179989
- KunitaAKashimaTGMorishitaYThe platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasisAm J Pathol200717041337134717392172
- ChandramohanVBaoXKato KanekoMRecombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumorsInt J Cancer2013132102339234823115013
- ChandramohanVBaoXKeirSTConstruction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapyClin Cancer Res201319174717472723857604
- BaoXChandramohanVKeirSTAntitumor efficacy of D2C7-(scdsFv)-PE38KDEL, a novel immunotoxin targeting EGFRwt and EGFRvIII, by convection-enhanced delivery in orthotopic brain tumor mouse modelsJ Immunother Cancer20131Suppl 1P126
- XieLYPiaoHLFanMImmunotoxin therapy for lung cancerChin Med J (Engl)2017130560761228229994
- HassanRAlewineCPastanINew life for immunotoxin cancer therapyClin Cancer Res20162251055105826463707
- GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269pl123550210
- CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
- KimMSPintoSMGetnetDA draft map of the human proteomeNature2014509750257558124870542
- KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853282457481
- MantelNEvaluation of survival data and two new rank order statistics arising in its considerationCancer Chemother Rep19665031631705910392
- CoxDRRegression models and life-tablesJ R Stat Soc B1972342187220
- SawyersCTargeted cancer therapyNature2004432701529429715549090
- AbaanODPolleyECDavisSRThe exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacologyCancer Res201373144372438223856246
- WickiALehembreFWickNHantuschBKerjaschkiDChristoforiGTumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeletonCancer Cell20069426127216616332
- YuYKhanJKhannaCHelmanLMeltzerPSMerlinoGExpression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulatorsNat Med200410217518114704789
- RodrigoJPGarcia-CarracedoDGonzalezMVManceboGFresnoMFGarcia-PedreroJPodoplanin expression in the development and progression of laryngeal squamous cell carcinomasMol Cancer201094820196862
- YuanPTemamSEl-NaggarAOverexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer2006107356356916804930
- HirschFRScagliottiGVMulshineJLLung cancer: current therapies and new targeted treatmentsLancet20173891006629931127574741
- SculierJPBerghmansTMeertAPAdvances in target therapy in lung cancerEur Respir Rev201524135232925726551
- RamirezMIMillienGHindsACaoYSeldinDCWilliamsMCT1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birthDev Biol20032561617212654292
- MahtabEAWijffelsMCVan Den AkkerNMCardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: correlation with abnormal epicardial developmentDev Dyn2008237384785718265012
- Martin-VillarESchollFGGamalloCCharacterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomasInt J Cancer2005113689991015515019
- LeshemYO’BrienJLiuXCombining local immunotoxins targeting mesothelin with CTLA-4 blockade synergistically eradicates murine cancer by promoting anticancer immunityCancer Immunol Res20175868569428674083
- World Health OrganizationCancer22018 Available from: http://www.who.int/mediacentre/factsheets/fs297/en/Accessed October 24, 2017
- World Health OrganizationTobacco in China Available from: http://www.wpro.who.int/china/mediacentre/factsheets/tobacco/en/Accessed November 19, 2017
- cBioPortal for Cancer Genetics Available from: http://www.cbioportal.orgAccessed September 15, 2017
- Human Proteome Map Available from: http://humanproteomemap.org/Accessed June 6, 2017
- American Type Culture Collection Available from: http://www.atcc.org